Biotech Values

[WorstLuck]

For Revance to hit it's 2024 projection they'll have to increase sales >24% in each of final three quarters

Do you see that happening? Hopefully, but that's a stretch.

We'll have to see what RHA-3 sales do to total RHA sales in Q2 to have a better idea. Playing with the numbers and some assumptions, RHA has to do some pretty heavy lifting even with optimistic Daxxy numbers. I have no idea what numbers to expect from the RHA-3 addition for the whole RHA collection so I'll just wait for Q2 results.